A5015277648- Patient-Provider Communication in Healthcare
- Head and Neck Cancer Studies
- Laser Applications in Dentistry and Medicine
- Oral health in cancer treatment
- Renal cell carcinoma treatment
- Cancer Genomics and Diagnostics
- Viral-associated cancers and disorders
- COVID-19 and Mental Health
- HIV/AIDS oral health manifestations
- Renal and related cancers
- Palliative Care and End-of-Life Issues
- Empathy and Medical Education
- COVID-19 and healthcare impacts
- Lymphoma Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Economic and Financial Impacts of Cancer
- IgG4-Related and Inflammatory Diseases
- Hip disorders and treatments
- Ear and Head Tumors
- Sarcoidosis and Beryllium Toxicity Research
- Advanced Authentication Protocols Security
- Hip and Femur Fractures
- Tumors and Oncological Cases
- Infective Endocarditis Diagnosis and Management
- Cutaneous lymphoproliferative disorders research
Universidade Estadual de Campinas (UNICAMP)
2019-2024
University of Florida
2022
Universidade Federal do Rio Grande do Sul
2022
Florida College
2022
Institut Gustave Roussy
2020-2022
Université Paris-Saclay
2020-2022
Universidade Federal da Bahia
2018-2021
Complexo Hospitalar Universitário Professor Edgard Santos
2018-2021
Instituto do Câncer do Estado de São Paulo
2019-2021
Universidade de São Paulo
2021
To evaluate whether the coronavirus disease 2019 has increased anxiety, depression, and distress levels in head neck cancer (HNC) patients undergoing radiotherapy (RT).In this cross-sectional study, RT-HNC were surveyed using Hospital Anxiety Depression Scale (HADS) for anxiety depression thermometer (DT) distress. HADS scores compared with data pre-COVID-19. Additionally, we evaluated COVID-19 impact on daily routines, treatment, care through a questionnaire.Fifty included. The mean score...
// Annalisa Guida 1 , 2 Gwénaël Le Teuff 3 4 Carolina Alves Emeline Colomba Vincenzo Di Nunno Lisa Derosa 5 Ronan Flippot Bernard Escudier and Laurence Albiges University of Modena Reggio Emilia, Modena, Italy Department Medical Oncology, Institute Gustave Roussy, Université Paris-Saclay, Villejuif, France Service de Biostatistique et d'Épidémiologie, CESP, Faculté médecinec-Université Paris-Sud, médecine - INSERM U1018, U1015, Correspondence to: Albiges, email:...
Abstract Primary manifestations of extraganglion non‐Hodgkin lymphoma (NHL) from T‐cells in the oral cavity are rare and often difficult to diagnose. Herein, we describe a case T‐cell NHL with primary lesion on lip diagnosed 25‐year‐old woman. The patient reported appearance initial upper lip, which advanced hard palate mucosa. Histological examination immunohistochemistry were compatible peripheral without further specifications. proposed treatment consisted six cycles multiagent...
Abstract PurposeTo assess the safety and efficacy of prophylactic extraoral photobiomodulation (PBM) for prevention oral oropharyngeal mucositis (OM) on clinical outcomes survival in patients with cavity squamous cell carcinoma (OOPSCC).MethodsOOPSCC who received radiotherapy (RT) were prospectively randomized to two groups: PBM placebo. OM grade (NCI), pain (VAS), analgesia, anti-inflammatory prescriptions assessed weekly. Quality life questionnaires (QoL) performed at first last day RT....
The aim of this article was to evaluate the clinical and laboratory profile people with oral Kaposi's sarcoma (KS) associated AIDS (KS-AIDS), followed-up at a public university hospital in Salvador, Bahia, Brazil, past 10 years. We identified patients diagnosed KS-AIDS, presenting manifestation from January 2007 December 2017. searched, information systems, patient demographics, diagnostic data, treatment, image studies, photographic records. Of 39 cases KS-AIDS institution, 14 (22.8%)...
Abstract Purpose: This study aimed to characterize the barriers faced by Brazilian dentists deliver bad news (DBN) about oral and oropharyngeal cancer diagnoses patients using a questionnaire based on guidelines of SPIKES protocol. Methods: was an observational cross-sectional study. The contained 27 questions protocol, which were answered in SurveyMonkey platform. Results : A total 186/249 questionnaire. main specialties reported 36.02% medicine, 21.5% pathology, 9.13% maxillofacial...
292 Background: Cabozantinib is a TKI with substantial efficacy in mRCC. It associated relevant tox leading frequent dose modifications (DM) or drug discontinuations (DD). While an exposure/safety relation has been demonstrated for this drug, exposure/efficacy still unknown. Cl/F measure of elimination from blood plasma and lower cabozantinib previously increased DM rate Methods: We performed monocentric PK (INDS MR 5612140520) study patients Blood draw assessment was at least 8 hours the...